Moonlake is an English word starting with the letter M. With 4 example sentences you'll see exactly how it works in context.
Moonlake in a sentence
Using Moonlake
- In the example corpus, moonlake often appears in combinations such as: moonlake immunotherapeutics, of moonlake.
Context around Moonlake
- Average sentence length in these examples: 22 words
- Position in the sentence: 1 start, 3 middle, 0 end
- Sentence types: 4 statements, 0 questions, 0 exclamations
Corpus analysis for Moonlake
- In this selection, "moonlake" usually appears in the middle of the sentence. The average example has 22 words, and this corpus slice is mostly made up of statements.
- Around the word, immunotherapeutics stand out and add context to how "moonlake" is used.
- Recognizable usage signals include shares of moonlake immunotherapeutics in and moonlake immunotherapeutics is. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "moonlake" sits close to words such as aaaaand, aaah and aaargh, which helps place it inside the broader word index.
Example types with moonlake
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
Needham & Company LLC started coverage on shares of MoonLake Immunotherapeutics in a report on Thursday, August 31st. (17 words)
Finally, Price T Rowe Associates Inc. MD increased its stake in shares of MoonLake Immunotherapeutics by 1.0% in the 1st quarter. (22 words)
Wedbush reissued an “outperform” rating and set a $92.00 target price on shares of MoonLake Immunotherapeutics in a research note on Friday. (23 words)
MoonLake Immunotherapeutics is trading at a lower price-to-earnings ratio than Ligand Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. (26 words)
Wedbush reissued an “outperform” rating and set a $92.00 target price on shares of MoonLake Immunotherapeutics in a research note on Friday. (23 words)
Finally, Price T Rowe Associates Inc. MD increased its stake in shares of MoonLake Immunotherapeutics by 1.0% in the 1st quarter. (22 words)
Example sentences (4)
Finally, Price T Rowe Associates Inc. MD increased its stake in shares of MoonLake Immunotherapeutics by 1.0% in the 1st quarter.
Needham & Company LLC started coverage on shares of MoonLake Immunotherapeutics in a report on Thursday, August 31st.
MoonLake Immunotherapeutics is trading at a lower price-to-earnings ratio than Ligand Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.
Wedbush reissued an “outperform” rating and set a $92.00 target price on shares of MoonLake Immunotherapeutics in a research note on Friday.
Common combinations with moonlake
These word pairs occur most frequently in English texts:
- moonlake immunotherapeutics 4×
- of moonlake 3×